Patent details

EP3209681 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING PEPTIDE VARIANTS AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP3209681
PCT Application Number:
US2015056830
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158533943
PCT Publication Number:
WO2016065106
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS COMPRISING PEPTIDE VARIANTS AND METHODS OF USE THEREOF
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES VARIANTS DE PEPTIDE ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT PEPTIDVARIANTEN UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
22/10/2015
Grant date:
02/04/2025
EP Publication Date:
30/08/2017
PCT Publication Date:
28/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/04/2025
EP B1 Publication Date:
02/04/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/03/2025
 
 

Name:
NGM Biopharmaceuticals, Inc.
Address:
333 Oyster Point Boulevard, South San Francisco, CA 94080, United States (US)

Agent

Name:
Calysta NV
From:
04/04/2025
Address:
5A Lambroekstraat, B-1831, DIEGEM - BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
LINDHOUT, Darrin, Anthony
Address:
United States (US)

2

Name:
OLSON, Charles, V.
Address:
United States (US)

Priority

Priority Number:
201462067824 P
Priority Date:
23/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/50; G01N 33/68; A61K 9/08; A61K 38/18; A61K 47/18; A61K 47/26; A61K 9/19; A61P 1/00; A61P 3/02; A61P 3/04; A61P 3/06; A61P 3/08; A61P 3/10; A61P 9/00; A61P 11/00; A61P 15/00; A61P 29/00; A61P 35/00; A61P 3/00;

Publication

European Patent Bulletin

Issue number:
202514
Publication date:
02/04/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
07/04/2025 Outgoing Correspondence 1
07/04/2025 Power Of Attorney 1